Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115088
Chunk: 535

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 535
---
 each case in accordance with the terms of such agreement. |

| • |     | Between February 15, 2023 and December 28, 2023, the Registrant has sold 1,414,554 shares of Common Stock pursuant to advances under the B. Riley Purchase Agreement. |

II-2

| • |     | Between February 16, 2023 and February 12, 2024, the Registrant sold 11,649,056 shares of Common Stock pursuant to advances under the A&R Yorkville Purchase Agreement. |

| • |     | On March 21, 2023, the Registrant entered into a securities purchase agreement with Yorkville, pursuant to which the Registrant sold and issued to Yorkville convertible debentures in the following aggregate principal amounts on the specified dates: (i) $10,000,000, on March 21, 2023, (ii) $7,500,000, on April 11, 2023, and (iii) $7,500,000, on April 20, 2023, each of which is convertible into shares of the Registrant’s Common Stock. In April 2023, Yorkville elected to convert $5.0 million of the outstanding principal and accrued interest of the convertible debentures, resulting in the issuance of 632,431 shares of the Registrant’s Common Stock at a conversion price of $8.00 per share. |

| • |     | On September 15, 2023, the Registrant entered into a settlement agreement with Cove Lane Onshore Fund, LLC (“Cove Lane”), HBC Investments LLC (“HBC”) and Hudson Bay Capital Management LP, pursuant to which the Registrant issued, on September 25, 2023, an aggregate of 474,683 shares of Common Stock, consisting of 161,392 shares of Common Stock to Cove Lane and 313,291 shares of Common Stock to HBC. |

| • |     | On September 21, 2023, the Registrant entered into the Securities Purchase Agreement, dated as of such date, with Oramed Pharmaceuticals Inc. (“Oramed”), pursuant to which, among other things, the Registrant issued to Oramed (i) a senior secured promissory note due 18 months from the date of issuance in the principal amount of $101,875,000 (ii) a warrant to purchase up to an aggregate of 4,500,000